The asset manager’s biotech portfolio managers see a strong setup for biotech stocks in the coming quarters.
Tag: Biotechnology
Will healthcare be the top investment theme in 2024?
The Novo Nordisk share price is up 51% over the past year, while Eli Lilly is up 84%.
Biotech sector is ripe with alpha: Janus Henderson
The biotech sector is filled with mispriced securities after an era of easy money in 2020, according to Janus Henderson’s Agustin Mohedas.
Genomics gain ground in investor portfolios
Investor interest in companies engaged in gene-based drug development is growing, according to Invesco.
Should investors bet on Covid-19 treatments?
Sentiment toward biotech companies may deteriorate again if efforts to develop treatments for Covid-19 prove to be unsuccessful, according to Polar Capital.
Janus Henderson launches thematic funds in Singapore
The funds are now available to Singapore retail investors and have been submitted to the SFC for sale in Hong Kong.
Janus Henderson explores biotech
The UK-based firm is the latest to join the growing number of asset managers that have launched thematic products in Asia.
